A new myeloblastic leukemia cell line with double minute chromosomes. Induction of methotrexate resistance and dihydrofolate reductase gene amplification.
To test the relationship between DMs and drug resistance in newly established AML cell lines, KY821, and its clone KY821A3, the latter had lost DMs during cloning, were cultured in increasing concentrations of MTX. KY821 became resistant against 2 x 10(-4) M MTX, whereas KY821A3 did against 2 x 10(-5) M MTX in a same period. Enhanced enzyme activities of DHFR were correspondent to the increased DMs numbers and DHFR gene amplification in both resistant clones. The amplified DHFR gene was located on DMs by in situ hybridization. These data indicated that the presence of DMs in KY821 would facilitate the acquisition of drug resistance.
Saito
H
H
Niigata University School of Medicine, First Department of Internal Medicine, Japan.
Kishi
K
K
Narita
M
M
Furukawa
T
T
Nagura
E
E
Maekawa
T
T
Abe
T
T
Shibata
A
A
D002869:Chromosome Aberrations; D003001:Cloning, Molecular; D004351:Drug Resistance / Q000235:genetics*; D005784:Gene Amplification / Q000235:genetics*; D016259:Genes, myc / Q000235:genetics; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000494:pharmacology*; D009693:Nucleic Acid Hybridization; D013762:Tetrahydrofolate Dehydrogenase / Q000235:genetics*; D014407:Tumor Cells, Cultured
D013762:Tetrahydrofolate Dehydrogenase; D008727:Methotrexate